Anna Garbuzov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anna Garbuzov has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Anastasiya Ivanko
Louisiana State University Health and Sciences Center , New Orleans, LA 70112 , USA
1 shared publicationBart Phillips
BData Inc , Minneapolis, MN 55424 , USA
1 shared publication- Corey Falcon
Ochsner Medical Center - New Orleans
1 shared publication Denise Danos
Louisiana State University Health and Sciences Center , New Orleans, LA 70112 , USA
1 shared publication- Erica Murata
BData, Inc. , Minneapolis, MN 55401
1 shared publication Herb A Phelan
Louisiana State University Health and Sciences Center , New Orleans, LA 70112 , USA
1 shared publication
Latest Publications
- 13 April 2024
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 45 (5) , 1095-1097
The Burden of Burns: An Analysis of Public Health Measures
Accurate analysis of injuries is paramount when allocating resources for prevention, research, education, and legislation. As burn mortality has improved over recent decades, the societal burden of burn injuries has grown ambiguous to the public while a scarcity of investigational funding for survivors has led to a gap in understanding lifelong sequela. We aim to compare national references reporting the incidence of burn injuries in the United States. The American Burn Association Burn Injury Summary Report (ABA-BISR), American Burn Association Fact Sheet, Centers for Disease Control and Prevention (CDC) Web-based Injury Statistics Query and Reporting (WISQARS) database, the CDC National Center for Health Statistics’ National Hospital Ambulatory Medical Care Survey (NHAMCS), National Inpatient Sample (NIS), National Emergency Department Sample (NEDS), and commercially available claims databases were queried for 2020 or the most recent data available. The BISR estimated 30,135 burn admissions in 2022. The 2016 ABA Fact Sheet reported 486,000 burns presented to US emergency departments (ED). In 2020, CDC’s WISQARS database reported 3,529 fatal, and 287,926 non-fatal, burn injuries. The 2020 NEDS reported 438,185 ED visits while the 2020 NIS estimated 103,235 inpatients. The NHAMCS reported 359,000 ED visits for burn injuries in the same period, and an analysis of ICD-10 burn codes demonstrated over 698,555 claims. Our study demonstrates a large variability in the reported incidence of burn injury by the ABA, CDC, national samples, and claims databases. Per our analyses, we estimate that 600,000 individuals annually suffer a burn injury which merits emergent care in the United States.
- 13 April 2024
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 45 (5) , 1095-1097
The Burden of Burns: An Analysis of Public Health Measures
Accurate analysis of injuries is paramount when allocating resources for prevention, research, education, and legislation. As burn mortality has improved over recent decades, the societal burden of burn injuries has grown ambiguous to the public while a scarcity of investigational funding for survivors has led to a gap in understanding lifelong sequela. We aim to compare national references reporting the incidence of burn injuries in the United States. The American Burn Association Burn Injury Summary Report (ABA-BISR), American Burn Association Fact Sheet, Centers for Disease Control and Prevention (CDC) Web-based Injury Statistics Query and Reporting (WISQARS) database, the CDC National Center for Health Statistics’ National Hospital Ambulatory Medical Care Survey (NHAMCS), National Inpatient Sample (NIS), National Emergency Department Sample (NEDS), and commercially available claims databases were queried for 2020 or the most recent data available. The BISR estimated 30,135 burn admissions in 2022. The 2016 ABA Fact Sheet reported 486,000 burns presented to US emergency departments (ED). In 2020, CDC’s WISQARS database reported 3,529 fatal, and 287,926 non-fatal, burn injuries. The 2020 NEDS reported 438,185 ED visits while the 2020 NIS estimated 103,235 inpatients. The NHAMCS reported 359,000 ED visits for burn injuries in the same period, and an analysis of ICD-10 burn codes demonstrated over 698,555 claims. Our study demonstrates a large variability in the reported incidence of burn injury by the ABA, CDC, national samples, and claims databases. Per our analyses, we estimate that 600,000 individuals annually suffer a burn injury which merits emergent care in the United States.
- Open Access
- 31 January 2024
- Published by Wiley
PEDIATRIC INTRACRANIAL INFLAMMATORY MYOFIBROBLASTIC TUMOR: A RARE CASE WITH DCTN1-ALK FUSION AND RESPONSE TO ALK INHIBITOR
Inflammatory myofibroblastic tumor (IMT) is a rare cancer that is most commonly found in children and young adults, and it is usually detected in the lungs and abdomen. IMT is often associated with an anaplastic lymphoma kinase (ALK) gene rearrangement. We report the case of a 17-year-old male with ALK positive intracranial IMT managed with surgical resection and entrectinib, an ALK inhibitor. This case shows the importance of gene sequencing in diagnosing central nervous system (CNS) tumors and the promising role of ALK inhibitors in IMT treatment. Hypersensitivity to alectinib resulting in successful substitution to entrectinib was also noteworthy.
- 31 January 2024
- Published by Wiley
Open AccessPEDIATRIC INTRACRANIAL INFLAMMATORY MYOFIBROBLASTIC TUMOR: A RARE CASE WITH DCTN1-ALK FUSION AND RESPONSE TO ALK INHIBITOR
Inflammatory myofibroblastic tumor (IMT) is a rare cancer that is most commonly found in children and young adults, and it is usually detected in the lungs and abdomen. IMT is often associated with an anaplastic lymphoma kinase (ALK) gene rearrangement. We report the case of a 17-year-old male with ALK positive intracranial IMT managed with surgical resection and entrectinib, an ALK inhibitor. This case shows the importance of gene sequencing in diagnosing central nervous system (CNS) tumors and the promising role of ALK inhibitors in IMT treatment. Hypersensitivity to alectinib resulting in successful substitution to entrectinib was also noteworthy.
- 17 March 2022
- Published by Springer Nature
- p. 275-292
Gender and Racial Disparities in Career Advancement in the United States
- 17 March 2022
- Published by Springer Nature
- p. 275-292
Gender and Racial Disparities in Career Advancement in the United States